Clin2
NCT07076979Possibly a fitRecruiting

Metabolic biomarkers for stomach cancer detection and monitoring

Gastric Cancer

Part of Cancer, Digestive system clinical trials.

This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
250 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 or older
  • You have been diagnosed with stomach adenocarcinoma (a type of stomach cancer) confirmed by biopsy
  • You have not had any prior cancer treatment (like chemotherapy or radiation)
  • You are generally active and able to care for yourself (ECOG score 0 or 1)
  • You do not have a family history of hereditary cancer
  • You are willing to provide blood and tumor tissue samples

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05991947Recruiting
Blood test for early stomach cancer detection

This study is testing a new way to find stomach (gastric) cancer early using a simple blood test. It may help people who have just been diagnosed with stage I, II, or III stomach cancer and have not started treatment yet.

Hangzhou, Zhejiang
NCT06232395Recruiting
Early detection and monitoring of stomach cancer

This study is looking for people with stomach discomfort who are coming to this hospital for an endoscopy. Researchers will use the test results to help catch stomach cancer early and keep an eye on it after surgery.

Shanghai, Shanghai Municipality
NCT07517107Recruiting· Phase 2
Blood tests to guide gastric cancer treatment decisions

This study uses special blood tests to detect cancer DNA and help doctors decide the best treatment plan for gastric cancer. The goal is to improve outcomes by personalizing therapy based on how your cancer responds.

Shanghai
NCT07374731Recruiting
Finding early signs of stomach cancer risk

This study looks for markers in the blood that could show if someone is at risk for stomach cancer or pre-cancerous changes. It aims to help catch problems earlier.

Aviano, Pordenone
NCT07782294Not yet recruiting
Blood test for early stomach cancer detection

This study uses a simple blood test to look for signs of stomach (gastric) cancer early. It may help detect cancer before symptoms appear, potentially improving treatment success.

Anyang, Henan
NCT05010863Recruiting
Test and develop a stomach cancer detection kit

This study looks for marker signals from stomach cancer tissue to improve a detection kit. You may be asked to provide tissue samples, especially if you have a new stomach cancer diagnosis and have not had anti-cancer treatment yet.

Wenzhou, Zhejiang

Hear when a new Gastric Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.